Work

Supplementary Tables from A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table 1. Adverse events at least possibly related to conatumumab treatment* Supplementary Table 2. Noncompartmental conatumumab pharmacokinetic parameters

DOI: 10.1158/1078-0432.22442178

Authors: Roy S. Herbst, Razelle Kurzrock, David S. Hong, Manuel Valdivieso, Cheng-Pang Hsu, Lovely Goyal, Gloria Juan, Yuying C. Hwang, Susan Wong, John S. Hill, Greg Friberg, Patricia M. LoRusso

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362393870

Cites:

Cited by:

Related to: 10